Numab Therapeutics AG

City:

Horgen

Country:

Switzerland

Published Applications:

Last publication date:

2023-06-22

Patent Grants:

Last grant date:

2025-01-21

Top Inventors for applications by Numab Therapeutics AG

These are the the leading inventors for applications assigned to Numab Therapeutics AG:

Tea Gunde 5 Zurich, Switzerland
Christian HESS 5 Zurich, Switzerland
David Urech 4 Jona, Switzerland
Alexandre SIMONIN 4 Rosenau, France

Sebastian MEYER 4 Eggenwil, Switzerland
Matthias BROCK 3 Aesch, Switzerland
Stefan Warmuth 2 Au, Switzerland

Recent patent applications by Numab Therapeutics AG

Numab Therapeutics AG based in Horgen, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-06-22 ✅ Patent 12,202,911 granted on 2025-01-21

US20230192897A1

Chemistry; metallurgy

Multispecific antibody comprising CD137 binding domain and PDL1 binding domain

#2 | 2022-10-20 ✅ Patent 11,879,005 granted on 2024-01-23

US20220332797A1

Chemistry; metallurgy

Hetero-dimeric multi-specific antibody format

#3 | 2022-04-28 ✅ Patent 12,503,505 granted on 2025-12-23

US20220127350A1

Chemistry; metallurgy

MULTISPECIFIC ANTIBODIES HAVING SPECIFICITY FOR TNFA AND IL-17A, ANTIBODIES TARGETING IL-17A, AND METHODS OF USE THEREOF

#4 | 2021-12-23 ✅ Patent 12,209,133 granted on 2025-01-28

US20210395379A1

Chemistry; metallurgy

Antibodies targeting CD137 and methods of use thereof

#5 | 2020-09-10 ✅ Patent 12,077,588 granted on 2024-09-03

US20200283528A1

Chemistry; metallurgy

Antibodies targeting PDL1 and methods of use thereof

#6 | 2020-06-11 ✅ Patent 12,098,203 granted on 2024-09-24

US20200181263A1

Chemistry; metallurgy

Hetero-dimeric multi-specific antibody format targeting at least CD3 and HSA

Also check out Numab Therapeutics AG's (Horgen, Switzerland) applicant profile with 6 patent applications submitted.

AssigneeID:

351446 ⎘